Glycogen and glycogen-hydrolysing lysosomal enzyme activity in mouse liver: effects of fasting, adrenoceptor antagonism and insulin-induced hypoglycaemia.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 2890262)

Published in Acta Physiol Scand on October 01, 1987

Authors

G Skoglund1, B Ahrén, C Rerup, A Stenström, I Lundquist

Author Affiliations

1: Department of Pharmacology, University of Lund, Sweden.

Articles by these authors

FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance. Cell (2001) 5.22

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus. N Engl J Med (1992) 4.37

High frequency of natural autoantibodies in normal newborn mice. J Immunol (1985) 2.17

Islet amyloid and type 2 diabetes mellitus. N Engl J Med (2000) 2.07

Fifty-two-week efficacy and safety of vildagliptin vs. glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin monotherapy. Diabetes Obes Metab (2009) 2.04

Serum calcium and survival in a large health screening program. J Clin Endocrinol Metab (1996) 1.76

Randomized clinical trial of the effect of interferon alpha on survival in patients with disseminated midgut carcinoid tumours. Br J Surg (2003) 1.74

Adrenal incidentaloma--experience of a standardized diagnostic programme in the Swedish prospective study. J Intern Med (2002) 1.74

Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care (2000) 1.54

Leptin is associated with increased risk of myocardial infarction. J Intern Med (1999) 1.52

Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia (2005) 1.51

Neuropeptidergic versus cholinergic and adrenergic regulation of islet hormone secretion. Diabetologia (1986) 1.49

Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2012) 1.49

A Palaeolithic diet improves glucose tolerance more than a Mediterranean-like diet in individuals with ischaemic heart disease. Diabetologia (2007) 1.42

Proximal closing wedge osteotomy and adductor tenotomy for treatment of hallux valgus. Foot Ankle (1989) 1.42

Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care (2001) 1.38

Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrinol Metab (1996) 1.37

Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice. Am J Physiol Endocrinol Metab (2001) 1.34

Extensive islet amyloid formation is induced by development of Type II diabetes mellitus and contributes to its progression: pathogenesis of diabetes in a mouse model. Diabetologia (1999) 1.34

Monoamines in the pancreatic islets of the mouse. Subcellular localization of 5-hydroxytryptamine by electron microscopic autoradiography. Diabetologia (1971) 1.33

Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis. Diabetes Obes Metab (2012) 1.30

Autonomic mediation of glucagon secretion during hypoglycemia: implications for impaired alpha-cell responses in type 1 diabetes. Diabetes (1998) 1.25

Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol (1998) 1.22

PAC1 receptor-deficient mice display impaired insulinotropic response to glucose and reduced glucose tolerance. J Clin Invest (2000) 1.19

Glucagon receptor antagonism improves islet function in mice with insulin resistance induced by a high-fat diet. Diabetologia (2007) 1.17

Colon cleansing regimens. A clinical study in 1200 patients. Gastrointest Radiol (1982) 1.17

B cell granule peptides affect human islet amyloid polypeptide (IAPP) fibril formation in vitro. Biochem Biophys Res Commun (1997) 1.13

Monoamines in the pancreatic islets of the mouse. 5-hydroxytryptamine as an intracellular modifier of insulin secretion, and the hypoglycaemic action of monoamine oxidase inhibitors. Diabetologia (1971) 1.11

Rate of normal longitudinal bone growth in the rat. Calcif Tissue Res (1972) 1.10

Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia (1998) 1.08

Long-term inhibition of dipeptidyl peptidase IV improves glucose tolerance and preserves islet function in mice. Eur J Endocrinol (2002) 1.08

Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance. Metabolism (2004) 1.07

Ibuprofen inhibits rat brain deamidation of anandamide at pharmacologically relevant concentrations. Mode of inhibition and structure-activity relationship. J Pharmacol Exp Ther (1997) 1.07

On the hyperglycaemic effect of DOPA and dopamine. Eur J Pharmacol (1967) 1.07

Calcitonin gene-related peptide: occurrence in pancreatic islets in the mouse and the rat and inhibition of insulin secretion in the mouse. Endocrinology (1986) 1.06

Long-term prognosis after healed amputation in patients with diabetes. Clin Orthop Relat Res (1998) 1.06

Increased insulin secretion and glucose tolerance in mice lacking islet amyloid polypeptide (amylin). Biochem Biophys Res Commun (1998) 1.05

Gastrectomy induces impaired insulin and glucagon secretion: evidence for a gastro-insular axis in mice. J Physiol (1999) 1.05

Sympathetic nerve stimulation versus pancreatic norepinephrine infusion in the dog: 1). Effects on basal release of insulin and glucagon. Endocrinology (1987) 1.05

Outflow paths of cells from the lymph node parenchyma to the efferent lymphatics--observations in thin section histology. Scand J Haematol (1969) 1.05

Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes (2001) 1.04

Blood glucose level in mice. 1. Evaluation of a new technique of multiple serial sampling. Acta Endocrinol (Copenh) (1966) 1.04

CART knock out mice have impaired insulin secretion and glucose intolerance, altered beta cell morphology and increased body weight. Regul Pept (2005) 1.03

Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke (1999) 1.03

Comparative evaluation of simple insulin sensitivity methods based on the oral glucose tolerance test. Diabetologia (2005) 1.02

Enhanced beta cell function and anti-inflammatory effect after chronic treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin in an advanced-aged diet-induced obesity mouse model. Diabetologia (2013) 1.02

Ten years experience of a diabetes clinic in northern Tanzania. East Afr Med J (1987) 1.01

Improved effect of glibenclamide on administration before breakfast. Eur J Clin Pharmacol (1982) 1.01

Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes. Proc Natl Acad Sci U S A (1993) 1.00

Cholecystokinin-A and cholecystokinin-B/gastrin receptor mRNA expression in the gastrointestinal tract and pancreas of the rat and man. A polymerase chain reaction study. Scand J Gastroenterol (1996) 0.99

Degree of starch gelatinization, digestion rate of starch in vitro, and metabolic response in rats. Am J Clin Nutr (1988) 0.99

A transplantable human carcinoid as model for somatostatin receptor-mediated and amine transporter-mediated radionuclide uptake. Am J Pathol (2001) 0.99

Clinical characteristics and outcome in 223 diabetic patients with deep foot infections. Foot Ankle Int (1997) 0.99

Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse. Cell Tissue Res (1992) 0.98

Homologous islet amyloid polypeptide: effects on plasma levels of glucagon, insulin and glucose in the mouse. Diabetes Res Clin Pract (1992) 0.98

Hormone-sensitive lipase, the rate-limiting enzyme in triglyceride hydrolysis, is expressed and active in beta-cells. Diabetes (1999) 0.98

PACAP stimulates insulin secretion but inhibits insulin sensitivity in mice. Am J Physiol (1998) 0.97

Clinical characteristics, treatment and survival in patients with pancreatic tumors causing hormonal syndromes. World J Surg (1992) 0.97

Calcitonin gene-related peptide in thyroid nerve fibers and C cells: effects on thyroid hormone secretion and response to hypercalcemia. Endocrinology (1986) 0.97

Glucagon dynamics during hypoglycaemia and food-re-challenge following treatment with vildagliptin in insulin-treated patients with type 2 diabetes. Diabetes Obes Metab (2014) 0.97

Islet constitutive nitric oxide synthase: biochemical determination and regulatory function. Am J Physiol (1996) 0.97

Plantar pressures in diabetic patients with foot ulcers which have remained healed. Diabet Med (2009) 0.97

Multicenter study of unicompartmental knee revision. PCA, Marmor, and St Georg compared in 3,777 cases of arthrosis. Acta Orthop Scand (1992) 0.96

Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans. Acta Physiol Scand (1997) 0.96

Low serum insulin in traditional Pacific Islanders--the Kitava Study. Metabolism (1999) 0.96

Inhibition of anandamide hydrolysis by the enantiomers of ibuprofen, ketorolac, and flurbiprofen. Arch Biochem Biophys (1999) 0.96

Evidence for the presence of glucose cycling in pancreatic islets of the ob/ob mouse. J Biol Chem (1989) 0.96

Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance. J Clin Endocrinol Metab (1999) 0.95

The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function. Diabetes (2001) 0.95

GLP-1(7-36) amide stimulates insulin secretion in rat islets: studies on the mode of action. Diabetes Res (1991) 0.95

Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion. Diabetologia (1977) 0.95

T-tubule endocytosis in dystrophic chicken muscle and its relation to muscle fiber degeneration. Acta Neuropathol (1979) 0.95

Effects of arginine on the secretion of insulin and islet amyloid polypeptide in humans. Pancreas (1995) 0.95

Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach? Diabet Med (1995) 0.94

beta-Adrenergic insulin release and adrenergic innervation of mouse pancreatic islets. Cell Tissue Res (1978) 0.94

Glucose-stimulated 45Calcium efflux from isolated rat pancreatic islets. J Clin Invest (1978) 0.94

Reduced GLP-1 and insulin responses and glucose intolerance after gastric glucose in GRP receptor-deleted mice. Am J Physiol Endocrinol Metab (2000) 0.94

Ca2+-independent phospholipase A2 contributes to the insulinotropic action of cholecystokinin-8 in rat islets: dissociation from the mechanism of carbachol. Diabetes (1998) 0.94

Fibrillar islet amyloid polypeptide differentially affects oxidative mechanisms and lipoprotein uptake in correlation with cytotoxicity in two insulin-producing cell lines. Biochem Biophys Res Commun (2000) 0.94

Sensitive method for determination of peroxidase activity in tissue by means of coupled oxidation reaction. Anal Biochem (1971) 0.93

Intermittent need for insulin in a subgroup of diabetic patients in Tanzania. Diabet Med (1985) 0.93

Monoamines in pancreatic islets of guinea pig, hamster, rat, and mouse determined by high performance liquid chromatography. Pancreas (1989) 0.93

Inhibitory effect of 2-deoxy-D-glucose on liver tumor growth in rats. Cancer Res (1992) 0.92

ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice. Diabetologia (2010) 0.92

Prevalence of diabetes mellitus in north-western Tanzania. Diabetologia (1984) 0.92

Feedback regulation of pancreatic enzyme secretion by intestinal trypsin in man. Digestion (1977) 0.92

Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretagogues. Br J Pharmacol (1995) 0.92

Differential changes in the 5-hydroxytryptamine and insulin content of guinea-pig B-cells. Endocrinology (1975) 0.92

Glucagon immunoreactivity in plasma from normal and dystrophic mice. Diabetologia (1982) 0.92

Helodermin-like peptides in thyroid C cells: stimulation of thyroid hormone secretion and suppression of calcium incorporation into bone. Proc Natl Acad Sci U S A (1989) 0.91

A strong association between biologically active testosterone and leptin in non-obese men and women is lost with increasing (central) adiposity. Int J Obes Relat Metab Disord (2001) 0.91

Glucose intolerance is predicted by low insulin secretion and high glucagon secretion: outcome of a prospective study in postmenopausal Caucasian women. Diabetologia (2000) 0.91

Intraoperative fall in plasma levels of intact parathyroid hormone after removal of one enlarged parathyroid gland in hyperparathyroid patients. Eur J Surg (1991) 0.91

Protein kinase B is expressed in pancreatic beta cells and activated upon stimulation with insulin-like growth factor I. Biochem Biophys Res Commun (1998) 0.91

What ails the β-cell? Diabetes Obes Metab (2010) 0.90

Prognostic value of systolic ankle and toe blood pressure levels in outcome of diabetic foot ulcer. Diabetes Care (1989) 0.90

Insulin resistant subjects lack islet adaptation to short-term dexamethasone-induced reduction in insulin sensitivity. Diabetologia (1999) 0.90